Literature DB >> 25411095

Resource modelling: the missing piece of the HTA jigsaw?

Praveen Thokala1, Simon Dixon, Beate Jahn.   

Abstract

Within health technology assessment (HTA), cost-effectiveness analysis and budget impact analyses have been broadly accepted as important components of decision making. However, whilst they address efficiency and affordability, the issue of implementation and feasibility has been largely ignored. HTA commonly takes place within a deliberative framework that captures issues of implementation and feasibility in a qualitative manner. We argue that only through a formal quantitative assessment of resource constraints can these issues be fully addressed. This paper argues the need for resource modelling to be considered explicitly in HTA. First, economic evaluation and budget impact models are described along with their limitations in evaluating feasibility. Next, resource modelling is defined and its usefulness is described along with examples of resource modelling from the literature. Then, the important issues that need to be considered when undertaking resource modelling are described before setting out recommendations for the use of resource modelling in HTA.

Mesh:

Year:  2015        PMID: 25411095     DOI: 10.1007/s40273-014-0228-9

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  36 in total

1.  EBM, HTA, and CER: clearing the confusion.

Authors:  Bryan R Luce; Michael Drummond; Bengt Jönsson; Peter J Neumann; J Sanford Schwartz; Uwe Siebert; Sean D Sullivan
Journal:  Milbank Q       Date:  2010-06       Impact factor: 4.911

Review 2.  Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment program.

Authors:  Colin H Ridyard; Dyfrig A Hughes
Journal:  Value Health       Date:  2010-10-12       Impact factor: 5.725

3.  Capacity constraints and cost-effectiveness: a discrete event simulation for drug-eluting stents.

Authors:  Beate Jahn; Karl Peter Pfeiffer; Engelbert Theurl; Jean-Eric Tarride; Ron Goeree
Journal:  Med Decis Making       Date:  2009-09-29       Impact factor: 2.583

4.  Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.

Authors:  Jonathan Karnon; James Stahl; Alan Brennan; J Jaime Caro; Javier Mar; Jörgen Möller
Journal:  Value Health       Date:  2012 Sep-Oct       Impact factor: 5.725

Review 5.  Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.

Authors:  J Jaime Caro; Andrew H Briggs; Uwe Siebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

Review 6.  The economic evaluation of medical devices: challenges ahead.

Authors:  Andreas Kirisits; W Ken Redekop
Journal:  Appl Health Econ Health Policy       Date:  2013-02       Impact factor: 2.561

7.  Resource-use measurement based on patient recall: issues and challenges for economic evaluation.

Authors:  Joanna C Thorn; Joanna Coast; David Cohen; William Hollingworth; Martin Knapp; Sian M Noble; Colin Ridyard; Sarah Wordsworth; Dyfrig Hughes
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

8.  A system dynamics model for planning cardiovascular disease interventions.

Authors:  Gary Hirsch; Jack Homer; Elizabeth Evans; Ann Zielinski
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

9.  Hospital-based health technology assessment on the use of mitral clips in the treatment of mitral regurgitation.

Authors:  Roberto Miniati; Giulio Cecconi; Fabrizio Dori; Matteo Marchetti; Guido Biffi Gentili; Barbara Porchia; Giorgio Presicce; Sara Franchi; Roberto Gusinu
Journal:  Technol Health Care       Date:  2013       Impact factor: 1.285

10.  Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.

Authors:  Jonathan Tosh; Ben Kearns; Alan Brennan; Glenys Parry; Thomas Ricketts; David Saxon; Alexis Kilgarriff-Foster; Anna Thake; Eleni Chambers; Rebecca Hutten
Journal:  BMC Health Serv Res       Date:  2013-04-26       Impact factor: 2.655

View more
  8 in total

Review 1.  Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment.

Authors:  Syed Salleh; Praveen Thokala; Alan Brennan; Ruby Hughes; Simon Dixon
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

Review 2.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

3.  Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.

Authors:  Deborah A Marshall; Luiza R Grazziotin; Dean A Regier; Sarah Wordsworth; James Buchanan; Kathryn Phillips; Maarten Ijzerman
Journal:  Value Health       Date:  2020-03-26       Impact factor: 5.725

4.  Health technology assessment of new retinal treatments; the need to capture healthcare capacity issues.

Authors:  Richard Gale; Oliver Cox; Craig Keenan; Usha Chakravarthy
Journal:  Eye (Lond)       Date:  2022-06-28       Impact factor: 4.456

5.  ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.

Authors:  Kristyna Lacinova; Praveen Thokala; Richard Nicholas; Pamela Dobay; Erik Scalfaro; Zuzanna Angehrn; Roisin Brennan; Ibolya Boer; Carol Lines; Nicholas Adlard
Journal:  Appl Health Econ Health Policy       Date:  2022-05-19       Impact factor: 3.686

6.  Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands.

Authors:  Anna Miquel-Cases; Lotte M G Steuten; Lisanne S Rigter; Wim H van Harten
Journal:  BMC Cancer       Date:  2016-09-05       Impact factor: 4.430

7.  Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach.

Authors:  Ru Han; Shuyao Liang; Clément François; Samuel Aballea; Emilie Clay; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2021-03-25

8.  Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.

Authors:  Stuart J Wright; William G Newman; Katherine Payne
Journal:  Med Decis Making       Date:  2021-10-25       Impact factor: 2.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.